Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.

Oncology reports - 1 Nov 2005

Okita Riki, Saeki Toshiaki, Takashima Shigemitsu, Yamaguchi Yoshiyuki, Toge Tetsuya

Abstract excerpt

It is well known that immunosuppression may contribute to the progression and chemotherapy-resistance of cancer. Recent studies have demonstrated that lymphocytes with the phenotype of CD4+CD25+ regulatory T cells (T-regs) contribute to immune dysfunction in cancer patients, and a relative increase in CD4+CD25+ regulatory T cells is related to immunosuppression and tumor progression in patients with some...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-Positive T-Lymphocytes

Share to Flow Cytometry

Share to Immunosuppression Therapy

Share to Lung Neoplasms

Share to Phenotype

Share to Receptors, Interleukin-2

Source

Identifiers

PMID: 16211295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.PMID 16211295Read ↗

CD4+CD25high regulatory cells in peripheral blood of cancer patients.Semantic proximity Read ↗

Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex.Semantic proximity Read ↗

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.Semantic proximity Read ↗

Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.Semantic proximity Read ↗

Targeting T regulatory (T reg ) cells in immunotherapy-resistant cancersSemantic proximity Read ↗

T regulatory cells control T‐cell proliferation partly by the release of soluble CD25 in patients with B‐cell malignanciesSemantic proximity Read ↗

CD4+CD25+-regulatory T cells from mouse to man.Semantic proximity Read ↗

CD25+ CD4+ regulatory T-cells in cancer.Semantic proximity Read ↗

Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma.Semantic proximity Read ↗

IRF4 is Correlated With the Conversion to a Th17-like Phenotype in Regulatory T Cells From the Malignant Pleural EffusionSemantic proximity Read ↗

The prognostic role of circulating CD8+ T cell proliferation in patients with untreated extensive stage small cell lung cancerSemantic proximity Read ↗

Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.